38 Week Extension Study to CAIN457C2303
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Uveitis
In brief
A 38-week extension to a 24 week multicenter, randomized, double-masked, placebo controlled study to assess the difference in the rate of recurrent exacerbations in Behçet's patients with posterior or panuveitis treated with AIN457 vs placebo adjunctive to standard-of-care immunosuppressive therapy
Key facts
- Study ID
- NCT01093846
- Run by
- Novartis Pharmaceuticals
- People needed
- 59
- Starts
- 2010-03-01
- Expected to finish
- 2011-01-01
- Last updated by the study team
- 2016-02-22
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Baltimore, Maryland, United States
- Novartis Investigative Site — Alexandria, Egypt
- Novartis Investigative Site — Grenoble, France
- Novartis Investigative Site — Heidelberg, Germany
- Novartis Investigative Site — Athens, GR, Greece
- Novartis Investigative Site — Ioannina, GR, Greece
- Novartis Investigative Site — Larissa, GR, Greece
- Novartis Investigative Site — Pátrai, Greece
- Novartis Investigative Site — Hong Kong, Hong Kong, Hong Kong
- Novartis Investigative Site — Ramat Gan, Israel
- Novartis Investigative Site — Tel Aviv, Israel
- Novartis Investigative Site — Amman, Jordan
- Novartis Investigative Site — Singapore, Singapore, Singapore
- Novartis Investigative Site — Seoul, Korea, South Korea
- Novartis Investigative Site — Seoul, Korea, South Korea
- Novartis Investigative Site — Barcelona, Catalonia, Spain
- Novartis Investigative Site — Barcelona, Catalonia, Spain
- Novartis Investigative Site — Lin-Ko, Taiwan
- Novartis Investigative Site — Sfax, Tunisia
- Novartis Investigative Site — Ankara, Turkey, Turkey (Türkiye)
- Novartis Investigative Site — Ankara, Turkey, Turkey (Türkiye)
- Novartis Investigative Site — Altindag / Ankara, Turkey (Türkiye)
- Novartis Investigative Site — Fatih / Istanbul, Turkey (Türkiye)
- Novartis Investigative Site — Istanbul, Turkey (Türkiye)
- Novartis Investigative Site — Izmir, Turkey (Türkiye)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.